[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GR3017547T3 - Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient. - Google Patents

Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.

Info

Publication number
GR3017547T3
GR3017547T3 GR950402574T GR950402574T GR3017547T3 GR 3017547 T3 GR3017547 T3 GR 3017547T3 GR 950402574 T GR950402574 T GR 950402574T GR 950402574 T GR950402574 T GR 950402574T GR 3017547 T3 GR3017547 T3 GR 3017547T3
Authority
GR
Greece
Prior art keywords
tablet
active ingredient
improved bioavailability
acid
dichloromethylenedephosphonic
Prior art date
Application number
GR950402574T
Other languages
English (en)
Inventor
Walter Preis
Bernd Muesel
Guenter Dr Neugebauer
Rolf-Dieter Dr Gabel
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3017547(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of GR3017547T3 publication Critical patent/GR3017547T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR950402574T 1993-05-15 1995-09-28 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient. GR3017547T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff

Publications (1)

Publication Number Publication Date
GR3017547T3 true GR3017547T3 (en) 1995-12-31

Family

ID=25927331

Family Applications (2)

Application Number Title Priority Date Filing Date
GR940300095T GR940300095T1 (en) 1993-05-15 1995-01-31 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.
GR950402574T GR3017547T3 (en) 1993-05-15 1995-09-28 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR940300095T GR940300095T1 (en) 1993-05-15 1995-01-31 Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.

Country Status (25)

Country Link
US (1) US5650168A (el)
EP (2) EP0625355B2 (el)
JP (1) JP3699110B2 (el)
KR (1) KR100263284B1 (el)
CN (1) CN1041797C (el)
AT (2) ATE128363T1 (el)
AU (1) AU687744B2 (el)
BR (1) BR9307859A (el)
CA (1) CA2162470C (el)
CZ (1) CZ287984B6 (el)
DE (1) DE59300688D1 (el)
DK (1) DK0625355T5 (el)
ES (1) ES2065313T5 (el)
FI (1) FI111519B (el)
GR (2) GR940300095T1 (el)
HU (1) HU220872B1 (el)
IL (1) IL106743A (el)
NO (1) NO307548B1 (el)
NZ (1) NZ254765A (el)
PL (1) PL173026B1 (el)
RU (1) RU2134103C1 (el)
SK (1) SK281193B6 (el)
TW (1) TW350772B (el)
UA (1) UA39884C2 (el)
WO (1) WO1994026310A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ20002567A3 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
EA013106B1 (ru) * 2003-09-19 2010-02-26 Сан Фарма Адвансед Ресьорч Компани Лтд. Оральная система доставки лекарственного препарата (варианты)
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
EP2177219A4 (en) * 2007-08-02 2010-09-29 Teijin Pharma Ltd PROPHYLACTIC OR THERAPEUTIC FOR DISEASES AS A RESULT OF ABNORMAL BONE MATERIAL CHANGE
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE
CN118370733B (zh) * 2024-06-21 2024-10-01 山东新时代药业有限公司 一种钙代谢调节药物氯膦酸二钠片及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
ATE60711T1 (de) * 1986-12-20 1991-02-15 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
HU215124B (hu) * 1991-02-26 1998-09-28 Norwich Eaton Pharmaceuticals, Inc. Eljárás csontritkulás (osteoporosis) kezelésére szolgáló ösztrogént és difoszfonátot tartalmazó, szinergetikus hatású gyógyszerkészítmények előállítására
SE501389C2 (sv) † 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
JPH08505142A (ja) * 1992-12-23 1996-06-04 メルク エンド カンパニー インコーポレーテッド 骨損失を治療及び予防するためのビスホスホネート／エストロゲン療法

Also Published As

Publication number Publication date
HU220872B1 (en) 2002-06-29
EP0625355A1 (de) 1994-11-23
ES2065313T1 (es) 1995-02-16
EP0697890A1 (de) 1996-02-28
DK0625355T3 (da) 1995-12-27
ES2065313T3 (es) 1995-12-01
US5650168A (en) 1997-07-22
FI111519B (fi) 2003-08-15
HUT70214A (en) 1995-09-28
DK0625355T5 (da) 2003-12-01
EP0625355B2 (de) 2003-06-25
CN1041797C (zh) 1999-01-27
HU9403160D0 (en) 1995-02-28
EP0625355B1 (de) 1995-09-27
JP3699110B2 (ja) 2005-09-28
NO944405L (no) 1994-11-24
SK4895A3 (en) 1997-01-08
AT128U1 (de) 1995-03-27
IL106743A0 (en) 1993-12-08
DE59300688D1 (de) 1995-11-02
CZ10095A3 (en) 1995-10-18
NO307548B1 (no) 2000-04-25
NO944405D0 (no) 1994-11-17
ATE128363T1 (de) 1995-10-15
UA39884C2 (uk) 2001-07-16
CA2162470C (en) 1998-06-16
PL173026B1 (pl) 1998-01-30
CZ287984B6 (cs) 2001-03-14
CA2162470A1 (en) 1994-11-24
PL307133A1 (en) 1995-05-02
SK281193B6 (sk) 2001-01-18
TW350772B (en) 1999-01-21
FI945313A0 (fi) 1994-11-11
GR940300095T1 (en) 1995-01-31
NZ254765A (en) 1997-02-24
BR9307859A (pt) 1996-01-09
JPH08509697A (ja) 1996-10-15
RU2134103C1 (ru) 1999-08-10
FI945313A (fi) 1994-12-13
KR100263284B1 (ko) 2000-08-01
AU687744B2 (en) 1998-03-05
DK0625355T4 (da) 2003-10-06
KR960702322A (ko) 1996-04-27
WO1994026310A1 (de) 1994-11-24
CN1095267A (zh) 1994-11-23
IL106743A (en) 1999-11-30
ES2065313T5 (es) 2004-01-01
AU4702093A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
GR3017547T3 (en) Tablet with improved bioavailability containing dichloromethylenedephosphonic acid as active ingredient.
UY23804A1 (es) Procedimiento de preparacion de medicamentos en forma de comprimidos con liberacion retardada de sustancia activa.
MXPA03007712A (es) Sales farmaceuticas.
WO2003011204A3 (en) Drug delivery systems
GR3019324T3 (en) Pharmaceutical chewing-gum containing acetylsalicylic acid
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
IE871584L (en) Sustained release capsule.
HUT43843A (en) Process for production of derivatives of benzimidasole and medical compounds containing thereof
GR3007202T3 (el)
HUT34350A (en) Prcess for production of partable pills with deferred decreasing of the reagents
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
CA2047027A1 (en) Tablet and granulate containing mesna as active substance
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
DE3064773D1 (en) Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives
UA32583C2 (uk) Похідні арилтіоалкілтіопіридину
HUT47081A (en) Process for producing pharmaceutical compositions against endogeneous parasites and a group of the active components, namely the new n-substituted oxy-carbonyl-esters
JPS5661357A (en) Benzazepin derivative* its manufacture and medicinal composition containing it
ZA887047B (en) Pharmaceutical products containing a 7-diphenylmethylenebicycloheptane or 7-diphenylmethylenebicycloheptene derivative,the use of these compounds as medicaments,and new 7-diphenylmethylenebicycloheptanes and 7-diphenylmethylenebicycloheptenes and processes for the preparation thereof
HU910229D0 (en) Process for producing 3-1-(5-thioxo-1-prolyl)-thiazolydine-4-carboxylic acid and its derivatives and pharmaceutical preparatives containing these compounds as active substance
RU96124097A (ru) Активатор дифференцировки нервных клеток
HU913832D0 (en) Process for the production of medical preparations in capsules, containing alcali-hydrogen-carbonates as active agents